A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...